Join
Live feed
·
INSIDERFilingvia Quantisnow
Aura Biosciences Inc. logo

Chief Technology Officer Plavsic Mark sold $72,723 worth of shares (7,383 units at $9.85), decreasing direct ownership by 6% to 121,132 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AURA· Aura Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AURA (Aura Biosciences Inc.) and more on Quantisnow.